Mail

UK markets closed

FTSE 100
7,531.59
+77.84(+1.04%)
FTSE 250
18,402.93
+169.46(+0.93%)
AIM
716.31
+2.53(+0.35%)
GBP/EUR
1.1657
+0.0066(+0.57%)
GBP/USD
1.2686
+0.0058(+0.46%)
Bitcoin GBP
30,596.06
+868.07(+2.92%)

9 on-the-market homes perfect for socialising

All these properties are tailor-made for entertaining family and friends

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.3784

+0.0105

(+2.85%)

As of 11:49AM EST. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	3.44M
Enterprise value	3.96M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.21
Price/book (mrq)	1.35
Enterprise value/revenue	1.39
Enterprise value/EBITDA	-3.33

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-99.24%
S&P500 52-week change ³	12.18%
52-week high ³	96.1000
52-week low ³	0.3200
50-day moving average ³	3.0851
200-day moving average ³	11.2974

Share statistics

Avg vol (3-month) ³	439.99k
Avg vol (10-day) ³	2.23M
Shares outstanding ⁵	9.36M
Implied shares outstanding ⁶	9.36M
Float ⁸	5.56M
% held by insiders ¹	11.74%
% held by institutions ¹	5.23%
Shares short (14 Nov 2023) ⁴	25.77k
Short ratio (14 Nov 2023) ⁴	0.05
Short % of float (14 Nov 2023) ⁴	0.29%
Short % of shares outstanding (14 Nov 2023) ⁴	0.28%
Shares short (prior month 12 Oct 2023) ⁴	185k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	12 Nov 2023

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 Jun 2023

Profitability

Profit margin	-54.24%
Operating margin (ttm)	-409.33%

Management effectiveness

Return on assets (ttm)	-67.01%
Return on equity (ttm)	-102.37%

Income statement

Revenue (ttm)	2.86M
Revenue per share (ttm)	1.48
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	3.84M
EBITDA	-10.98M
Net income avi to common (ttm)	-1.55M
Diluted EPS (ttm)	-3.5900
Quarterly earnings growth (yoy)	-31.00%

Balance sheet

Total cash (mrq)	1.92M
Total cash per share (mrq)	0.33
Total debt (mrq)	2.45M
Total debt/equity (mrq)	122.09%
Current ratio (mrq)	1.09
Book value per share (mrq)	0.35

Cash flow statement

Operating cash flow (ttm)	-12.19M
Levered free cash flow (ttm)	-9.9M